Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Chordoma

• Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
• An Open-label, Single-arm, Interventional Clinical Study to Evaluate the Efficacy of Afatinib in Skull Base Chordom
• Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors
• Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors
• Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
• Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma
• Pemetrexed for the Treatment of Chordoma
• QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.
• Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
• Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers
• CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma
• Afatinib in Locally Advanced and Metastatic Chordoma
• A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
• A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
• Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers
• A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
• Nilotinib With Radiation for High Risk Chordoma
• Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
• Trial of Dasatinib in Advanced Sarcomas
• Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer
• Efficacy and Safety of Imatinib in Chordoma
• Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors